Keywords
Cardiovascular Diseases
HIV
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the prevalence of cardiovascular diseases in patients with HIV. Methods: This is an integrative review of the literature, which searched for clinical studies published in English, Portuguese or Spanish in the last 5 years in the Medline/PubMed, Scopus and LILACS databases using inclusion and exclusion criteria as well. information. Results: After a thorough study selection process, 23 clinical articles were included in the final sample. In total, there were 30,577 patients, of which 28,716 were people living with HIV (HIV+) and 1,861 people with a negative HIV test (HIV-). Several cardiovascular diseases (CVD) were observed, with emphasis on Systemic Arterial Hypertension. The association with sex, age, CD4 count, viral load and average time of HIV infection has been proven in most studies. All studies showed a higher prevalence of proven CVD when compared to the general population, with the exception of one study. Final considerations: Therefore, it is considered that CVDs are more prevalent in people living with HIV. Therefore, closer management of these conditions in these patients is necessary.
References
ADEDOKUN TA, et al. Prevalence and risk factors for subclinical atherosclerosis amongst adults living with HIV in University of Abuja Teaching Hospital, Gwagwalada. Frontiers in Reproductive Health, 2023; 5: 1092211.
AHMED HA, et al. Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study. BMJ open, 2022; 12(6): e062352.
ARODIWE IO, et al. Left ventricular hypertrophy in African children infected with HIV/AIDS: a case-control study. The Pan African Medical Journal, 2023; 45.
ATHANASIADI E, et al. Subclinical Left Ventricular Systolic Dysfunction in HIV Patients: Prevalence and Associations with Carotid Atherosclerosis and Increased Adiposity. Journal of Clinical Medicine, 2022; 11(7): 1804.
BIBANGAMBAH P, et al. Prevalence and correlates of carotid plaque in a mixed HIV-serostatus cohort in Uganda. BMC Cardiovascular Disorders, 2021; 21(1): 1-7.
COSTA AN, et al. Increased prevalence of hypertension among people living with HIV: where to begin? Revista da Sociedade Brasileira de Medicina Tropical, 2020; 53.
COSTA FCA, et al. Perfil informacional de uma população jovem a respeito da AIDS e suas consequências. Revista Eletrônica Acervo Saúde, 2020; 47: e3173.
COSTA FS, et al. Pessoas convivendo com HIV/AIDS: perfil clínico sócio demográfico de coinfectados por toxoplasmose em um serviço de assistência especializada. Revista Eletrônica Acervo Saúde, 2016; 4: 141-149.
DZUDIE A, et al. Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS. Plos one, 2021; 16(7): e0253742.
HAMEAU R, et al. Enfermedad coronaria en el paciente portador del virus de la inmunodeficiencia humana. Revista chilena de cardiología, 2021; 40(2): 139-147.
HEMKENS LG e BUCHER HC. HIV infection and cardiovascular disease. European heart journal, 2014; 35(21): 1373-1381.
HERAVI AS, et al. HIV infection is associated with variability in ventricular repolarization: the multicenter AIDS cohort study (MACS). Circulation, 2020; 141(3): 176-187.
HERTZ JT, et al. Prevalence and predictors of uncontrolled hypertension, diabetes, and obesity among adults with HIV in northern Tanzania. Global Public Health, 2022; 17(12): 3747-3759.
JACKSON IL, et al. Prevalence and control of hypertension among people living with HIV receiving care at a Nigerian hospital. Pan African Medical Journal, 2022; 41(1).
KNUDSEN AD, et al. Coronary artery disease in persons with HIV without detectable viral replication. In Open Forum Infectious Diseases (p. ofad298). Oxford University Press, 2023.
LONGENECKER CT, et al. O sexo modifica a associação entre o VIH e a doença arterial coronária entre os idosos no Uganda. Jornal da Sociedade Internacional de AIDS, 2022; 25 (1): e25868.
MAGALHÃES LBNC, et al. Conceito e aspectos epidemiológicos da hipertensão arterial. Rev Bras Hipertens, 2018; 25(1): 6-12.
MAHALIE R, et al. Predictors of cardiovascular diseases among people living with HIV initiated on antiretroviral therapy in Khomas region, Namibia: A cross-sectional study. Journal of Public Health in Africa, 2022; 13(1).
MANAVALAN P, et al. Hypertension among adults enrolled in HIV care in northern Tanzania: comorbidities, cardiovascular risk, and knowledge, attitudes and practices. Pan African Medical Journal, 2022; 41(1).
MENDES KDS et al. Revisão Integrativa: Método de Pesquisa para a Incorporação de Evidências na Saúde e na Enfermagem. Texto Contexto Enferm., 2008; 17(4): 758-764.
MELO BDO, et al. Epidemiologia e aspectos imunopatológicos do vírus da imunodeficiência humana (HIV): revisão de literatura. Revista Ceuma Perspectivas, 2018, 31(1): 86-100.
MOGAKA, J et al. Prevalence and factors associated with hypertension among adults with and without HIV in Western Kenya. Plos one, 2022; 17(1): e0262400.
PAISIBLE AL, et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015, 68(2): 209-216.
PRODANOV CC e FREITAS EC. Metodologia do trabalho científico [recurso eletrônico]: métodos e técnicas da pesquisa e do trabalho acadêmico. 2. ed. Novo Hamburgo: Feevale, 2013.
ODUBELA O, et al. Prevalence of hypertension among antiretroviral therapy naïve patients in Lagos, Nigeria. Clinical Hypertension, 2023; 29(1): 29.
ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE (OPAS). 2020. In: Dia Mundial da Hipertensão 2020. Disponível em: https://www.paho.org/pt/campanhas/dia-mundial-da-hipertensao-2020#:~:text=A%20hipertens%C3%A3o%20afeta%20mais%20de,insufici%C3%AAncia%20card%C3%ADaca%2C%20arritmia%20e%20dem%C3%AAncia. Acessado em: 8 de outubro de 2023.
REMCH M, et al. Hypertension burden, treatment, and control among people with HIV at a clinical care center in the Southeastern US, 2014–2019. AIDS care, 2023; 35(10): 1594-1603.
RIBEIRO VF, et al. Estudo epidemiológico sobre o vírus da imunodeficiência humana (HIV) em indígenas do estado de Roraima entre 2010 a 2018. Revista Eletrônica Acervo Saúde, 2020; 12(7): e3447.
SALMAZO PS, et al. Frequência de Aterosclerose Subclínica em Brasileiros Infectados pelo HIV. Arquivos Brasileiros de Cardiologia, 2018; 110: 402-410.
SEMULIMI AW, et al. Review of electrocardiographic abnormalities among people living with HIV in Sub-Saharan Africa: A systematic review. Plos one, 2023; 18(3): e0283419.
SHITOLE SG, et al. Human immunodeficiency virus and cardiac end-organ damage in women: findings from an echocardiographic study across the United States. Clinical infectious diseases, 2023; 76(2): 210-219.
SIDDIQUI M, et al. Risk factors for incident hypertension within 1 year of initiating antiretroviral therapy among people with HIV. AIDS Research and Human Retroviruses, 2022; 38(9): 735-742.
SO-ARMAH K e FREIBERG MS. HIV and cardiovascular disease: update on clinical events, special populations, and novel biomarkers. Current HIV/AIDS Reports, 2018; 15: 233-244.
SO‐ARMAH KA, et al. FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients. Hepatology, 2017; 66(4): 1286-1295.
SOUZA MT, et al. Integrative review: what is it? How to do it? Einstein, 2010; 8(1): 102-106.
TRIANT VA. Cardiovascular disease and HIV infection. Current HIV/AIDS Reports, 2013; 10: 199-206.
VENUGOPALAN A, et al. Prevalence of non-communicable disease in HIV infected patients coming to emergency medicine and Critical Care Department in a Tertiary Care Centre in South India. Research Journal of Pharmacy and Technology, 2023; 16(4): 1743-1748.
VERDEJO-MUÑOZ G, et al. Capilaroscopia, microangiopatía y VIH. Estudio descriptivo de hallazgos capilaroscópicos en pacientes con VIH. In Anales del Sistema Sanitario de Navarra, 2022; 45(3).
ZANUZZI MG, et al. Hipertensión y síndrome metabólico en pacientes con Virus de la Inmunodeficiencia-Humana. MEDICINA (Buenos Aires), 2020; 80(5): 453-461.